{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:05:25Z","timestamp":1793480725164,"version":"4.5.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Society for the Promotion of Research in Experimental Neurology, Vienna, Austria"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00702-023-02613-w","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T08:02:46Z","timestamp":1677744166000},"page":"481-493","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pathomechanisms of cognitive impairment in progressive supranuclear palsy"],"prefix":"10.1007","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9641-7649","authenticated-orcid":false,"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"2613_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101899","volume":"23","author":"A Abos","year":"2019","unstructured":"Abos A, Segura B, Baggio HC, Campabadal A, Uribe C, Garrido A, Camara A, Mu\u00f1oz E, Valldeoriola F, Marti MJ, Junque C, Compta Y (2019) Disrupted structural connectivity of fronto-deep gray matter pathways in progressive supranuclear palsy. Neuroimage Clin 23:101899","journal-title":"Neuroimage Clin"},{"key":"2613_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1267\/ahc.21-00019","volume":"54","author":"ZH Abu Bakar","year":"2021","unstructured":"Abu Bakar ZH, Kato T, Yanagisawa D, Bellier JP, Mukaisho KI, Tooyama I (2021) Immunohistochemical study of mitochondrial ferritin in the midbrain of patients with progressive supranuclear palsy. Acta Histochem Cytochem 54:97\u2013104","journal-title":"Acta Histochem Cytochem"},{"key":"2613_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/ijms23010537","volume":"23","author":"ZH Abu Bakar","year":"2022","unstructured":"Abu Bakar ZH, Bellier JP, Yanagisawa D, Kato T, Mukaisho KI, Tooyama I (2022) LC3\/FtMt colocalization patterns reveal the progression of FtMt accumulation in nigral neurons of patients with progressive supranuclear palsy. Int J Mol Sci  23:537. https:\/\/doi.org\/10.3390\/ijms23010537","journal-title":"Int J Mol Sci"},{"key":"2613_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac1471","author":"NE Adams","year":"2022","unstructured":"Adams NE, Jafarian A, Perry A, Rouse MA, Shaw AD, Murley AG, Cope TE, Bevan-Jones WR, Passamonti L, Street D, Holland N, Nesbitt D, Hughes LE, Friston KJ, Rowe JB (2022) Neurophysiological consequences of synapse loss in progressive supranuclear palsy. Brain Online. https:\/\/doi.org\/10.1093\/brain\/awac1471","journal-title":"Brain"},{"key":"2613_CR5","volume-title":"Progressive Supranuclear Palsy, 2022\/04\/03 Edition","author":"S Agarwal","year":"2022","unstructured":"Agarwal S, Gilbert R (2022) Progressive Supranuclear Palsy, 2022\/04\/03 Edition. StatPearls Publishing, Treasure Island, FL"},{"key":"2613_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00259-022-05952-0","volume":"50","author":"G Aghakhanyan","year":"2022","unstructured":"Aghakhanyan G, Rullmann M, Rumpf J, Schroeter ML, Scherlach C, Patt M, Brendel M, Koglin N, Stephens AW, Classen J, Hoffmann KT, Sabri O, Barthel H (2022) Interplay of tau and functional network connectivity in progressive supranuclear palsy: a [(18)F]PI-2620 PET\/MRI study. Eur J Nucl Med Mol Imaging 50:103\u2013114","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2613_CR7","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00415-014-7301-3","volume":"261","author":"F Agosta","year":"2014","unstructured":"Agosta F, Galantucci S, Svetel M, Lukic MJ, Copetti M, Davidovic K, Tomic A, Spinelli EG, Kostic VS, Filippi M (2014) Clinical, cognitive, and behavioural correlates of white matter damage in progressive supranuclear palsy. J Neurol 261:913\u2013924","journal-title":"J Neurol"},{"key":"2613_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/14737175.2018.1489241","volume":"18","author":"F Ali","year":"2018","unstructured":"Ali F, Josephs K (2018) The diagnosis of progressive supranuclear palsy: current opinions and challenges. Expert Rev Neurother 18:603\u2013616","journal-title":"Expert Rev Neurother"},{"key":"2613_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fneur.2020.00180","volume":"11","author":"P Alster","year":"2020","unstructured":"Alster P, Madetko N, Koziorowski D, Friedman A (2020a) Progressive supranuclear palsy-parkinsonism predominant (PSP-P) - A clinical challenge at the boundaries of PSP and Parkinson\u2019s disease (PD). Front Neurol 11:180","journal-title":"Front Neurol"},{"key":"2613_CR10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3389\/fnins.2020.00893","volume":"14","author":"P Alster","year":"2020","unstructured":"Alster P, Madetko N, Koziorowski D, Friedman A (2020b) Microglial activation and inflammation as a factor in the pathogenesis of progressive supranuclear palsy (PSP). Front Neurosci 14:893","journal-title":"Front Neurosci"},{"key":"2613_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1468-1331.2006.01139.x","volume":"13","author":"K Aoyama","year":"2006","unstructured":"Aoyama K, Matsubara K, Kobayashi S (2006) Aging and oxidative stress in progressive supranuclear palsy. Eur J Neurol 13:89\u201392","journal-title":"Eur J Neurol"},{"key":"2613_CR12","doi-asserted-by":"publisher","first-page":"fcac040","DOI":"10.1093\/braincomms\/fcac040","volume":"4","author":"D B\u00e4ckstr\u00f6m","year":"2022","unstructured":"B\u00e4ckstr\u00f6m D, Gran\u00e5sen G, Mo SJ, Riklund K, Trupp M, Zetterberg H, Blennow K, Forsgren L, Domell\u00f6f ME (2022) Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study. Brain Commun 4:fcac040","journal-title":"Brain Commun"},{"key":"2613_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/13554790590962997","volume":"11","author":"TH Bak","year":"2005","unstructured":"Bak TH, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR (2005) Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase 11:268\u2013273","journal-title":"Neurocase"},{"key":"2613_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00005072-199904000-00006","volume":"58","author":"EH Bigio","year":"1999","unstructured":"Bigio EH, Brown DF, White CL 3rd (1999) Progressive supranuclear palsy with dementia: cortical pathology. J Neuropathol Exp Neurol 58:359\u2013364","journal-title":"J Neuropathol Exp Neurol"},{"key":"2613_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000068502","volume":"49","author":"B Boeve","year":"2003","unstructured":"Boeve B, Dickson D, Duffy J, Bartleson J, Trenerry M, Petersen R (2003) Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology. Eur Neurol 49:72\u201378","journal-title":"Eur Neurol"},{"key":"2613_CR16","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/BF00304466","volume":"84","author":"H Braak","year":"1992","unstructured":"Braak H, Jellinger K, Braak E, Bohl J (1992) Allocortical neurofibrillary changes in progressive supranuclear palsy. Acta Neuropathol 84:478\u2013483","journal-title":"Acta Neuropathol"},{"key":"2613_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fnagi.2017.00440","volume":"9","author":"M Brendel","year":"2018","unstructured":"Brendel M, Sch\u00f6necker S, H\u00f6glinger G, Lindner S, Havla J, Blautzik J, Sauerbeck J, Rohrer G, Zach C, Vettermann F, Lang AE, Golbe L, N\u00fcbling G, Bartenstein P, Furukawa K, Ishiki A, B\u00f6tzel K, Danek A, Okamura N, Levin J, Rominger A (2018) [(18)F]-THK5351 PET correlates with topology and symptom severity in progressive supranuclear palsy. Front Aging Neurosci 9:440","journal-title":"Front Aging Neurosci"},{"key":"2613_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12914","volume":"31","author":"N Briel","year":"2021","unstructured":"Briel N, Pratsch K, Roeber S, Arzberger T, Herms J (2021) Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration. Brain Pathol 31:e12914","journal-title":"Brain Pathol"},{"key":"2613_CR19","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/brain\/awq158","volume":"133","author":"RG Brown","year":"2010","unstructured":"Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, Agid Y, Ludolph A, Bensimon G, Payan C, Leigh NP (2010) Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 133:2382\u20132393","journal-title":"Brain"},{"key":"2613_CR20","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.nicl.2017.09.008","volume":"16","author":"JA Brown","year":"2017","unstructured":"Brown JA, Hua AY, Trujllo A, Attygalle S, Binney RJ, Spina S, Lee SE, Kramer JH, Miller BL, Rosen HJ, Boxer AL, Seeley WW (2017) Advancing functional dysconnectivity and atrophy in progressive supranuclear palsy. Neuroimage Clin 16:564\u2013574","journal-title":"Neuroimage Clin"},{"key":"2613_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/mds.25872","volume":"29","author":"JR Burrell","year":"2014","unstructured":"Burrell JR, Hodges JR, Rowe JB (2014) Cognition in corticobasal syndrome and progressive supranuclear palsy: a review. Mov Disord 29:684\u2013693","journal-title":"Mov Disord"},{"key":"2613_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00702-023-02591-z","volume":"130","author":"M Campagnolo","year":"2023","unstructured":"Campagnolo M, Weis L, Fogliano C, Cianci V, Garon M, Fiorenzato E, Carecchio M, Ferreri F, Bisiacchi P, Antonini A, Biundo R (2023) Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes. J Neural Transm (vienna) 130:97\u2013109","journal-title":"J Neural Transm (vienna)"},{"key":"2613_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2016.07.007","volume":"31","author":"F Caso","year":"2016","unstructured":"Caso F, Agosta F, Volont\u00c3\u00a9 MA, Ferraro PM, Tiraboschi P, Copetti M, Valsasina P, Falautano M, Comi G, Falini A, Filippi M, (2016) Cognitive impairment in progressive supranuclear palsy-Richardson\u2019s syndrome is related to white matter damage. Parkinsonism Relat Disord 31:65\u201371","journal-title":"Parkinsonism Relat Disord"},{"key":"2613_CR24","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/mds.27702","volume":"34","author":"Z Chen","year":"2019","unstructured":"Chen Z, Chen JA, Shatunov A, Jones AR, Kravitz SN, Huang AY, Lawrence L, Lowe JK, Lewis CM, Payan CAM, Lieb W, Franke A, Deloukas P, Amouyel P, Tzourio C, Dartigues JF, Ludolph A, Bensimon G, Leigh PN, Bronstein JM, Coppola G, Geschwind DH, Al-Chalabi A (2019) Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy. Mov Disord 34:1049\u20131059","journal-title":"Mov Disord"},{"key":"2613_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/mds.26844","volume":"32","author":"H Cho","year":"2017","unstructured":"Cho H, Choi JY, Hwang MS, Lee SH, Ryu YH, Lee MS, Lyoo CH (2017) Subcortical (18) F-AV-1451 binding patterns in progressive supranuclear palsy. Mov Disord 32:134\u2013140","journal-title":"Mov Disord"},{"key":"2613_CR26","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/brain\/awx347","volume":"141","author":"TE Cope","year":"2018","unstructured":"Cope TE, Rittman T, Borchert RJ, Jones PS, Vatansever D, Allinson K, Passamonti L, Vazquez Rodriguez P, Bevan-Jones WR, O\u2019Brien JT, Rowe JB (2018) Tau burden and the functional connectome in Alzheimer\u2019s disease and progressive supranuclear palsy. Brain 141:550\u2013567","journal-title":"Brain"},{"key":"2613_CR27","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/brain\/awh508","volume":"128","author":"NJ Cordato","year":"2005","unstructured":"Cordato NJ, Duggins AJ, Halliday GM, Morris JG, Pantelis C (2005) Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 128:1259\u20131266","journal-title":"Brain"},{"key":"2613_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.parkreldis.2020.04.014","volume":"73","author":"DG Coughlin","year":"2020","unstructured":"Coughlin DG, Litvan I (2020) Progressive supranuclear palsy: Advances in diagnosis and management. Parkinsonism Relat Disord 73:105\u2013116","journal-title":"Parkinsonism Relat Disord"},{"key":"2613_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-3-030-51140-1_11","volume":"1281","author":"DG Coughlin","year":"2021","unstructured":"Coughlin DG, Dickson DW, Josephs KA, Litvan I (2021) Progressive supranuclear palsy and corticobasal degeneration. Adv Exp Med Biol 1281:151\u2013176","journal-title":"Adv Exp Med Biol"},{"key":"2613_CR30","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1111\/ene.15346","volume":"29","author":"B Couto","year":"2022","unstructured":"Couto B, Martinez-Valbuena I, Lee S, Alfradique-Dunham I, Perrin RJ, Perlmutter JS, Cruchaga C, Kim A, Visanji N, Sato C, Rogaeva E, Lang AE, Kovacs GG (2022) Protracted course progressive supranuclear palsy. Eur J Neurol 29:2220\u20132231","journal-title":"Eur J Neurol"},{"key":"2613_CR31","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000002638","volume":"86","author":"IT Coyle-Gilchrist","year":"2016","unstructured":"Coyle-Gilchrist IT, Dick KM, Patterson K, V\u00e1zquez Rodr\u00edquez P, Wehmann E, Wilcox A, Lansdall CJ, Dawson KE, Wiggins J, Mead S, Brayne C, Rowe JB (2016) Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology 86:1736\u20131743","journal-title":"Neurology"},{"key":"2613_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cortex.2022.07.015","volume":"155","author":"LC de Souza","year":"2022","unstructured":"de Souza LC, Bertoux M, Radakovic R, Hornberger M, Mariano LI, Resende EPF, Quesque F, Guimar\u00e3es HC, Gambogi LB, Tumas V, Camargos ST, Cardoso FEC, Teixeira AL, Caramelli P (2022) I\u2019m looking through you: Mentalizing in frontotemporal dementia and progressive supranuclear palsy. Cortex 155:373\u2013389","journal-title":"Cortex"},{"key":"2613_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/09727531221089396","volume":"29","author":"M Debnath","year":"2022","unstructured":"Debnath M, Dey S, Sreenivas N, Pal PK, Yadav R (2022) Genetic and epigenetic constructs of progressive supranuclear palsy. Ann Neurosci 29:177\u2013188","journal-title":"Ann Neurosci"},{"key":"2613_CR34","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","volume":"23","author":"DW Dickson","year":"2010","unstructured":"Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA (2010) Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 23:394\u2013400","journal-title":"Curr Opin Neurol"},{"key":"2613_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.102009","volume":"24","author":"A Dodich","year":"2019","unstructured":"Dodich A, Cerami C, Inguscio E, Iannaccone S, Magnani G, Marcone A, Guglielmo P, Vanoli G, Cappa SF, Perani D (2019) The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy. Neuroimage Clin 24:102009","journal-title":"Neuroimage Clin"},{"key":"2613_CR36","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1212\/01.wnl.0000267643.24870.26","volume":"69","author":"L Donker Kaat","year":"2007","unstructured":"Donker Kaat L, Boon AJ, Kamphorst W, Ravid R, Duivenvoorden HJ, van Swieten JC (2007) Frontal presentation in progressive supranuclear palsy. Neurology 69:723\u2013729","journal-title":"Neurology"},{"key":"2613_CR37","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/13803395.2019.1572073","volume":"41","author":"K Duff","year":"2019","unstructured":"Duff K, McDermott D, Luong D, Randolph C, Boxer AL (2019) Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status. J Clin Exp Neuropsychol 41:469\u2013475","journal-title":"J Clin Exp Neuropsychol"},{"key":"2613_CR38","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. a meta-analysis. APOE and alzheimer disease meta analysis consortium. JAMA 278:1349\u20131356","journal-title":"JAMA"},{"key":"2613_CR39","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00702-019-02065-1","volume":"126","author":"E Fiorenzato","year":"2019","unstructured":"Fiorenzato E, Antonini A, Camparini V, Weis L, Semenza C, Biundo R (2019) Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson\u2019s disease. J Neural Transm (vienna) 126:1437\u20131445","journal-title":"J Neural Transm (vienna)"},{"key":"2613_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.parkreldis.2018.03.030","volume":"54","author":"V Fleury","year":"2018","unstructured":"Fleury V, Brindel P, Nicastro N, Burkhard PR (2018) Descriptive epidemiology of parkinsonism in the Canton of Geneva, Switzerland. Parkinsonism Relat Disord 54:30\u201339","journal-title":"Parkinsonism Relat Disord"},{"issue":"24","key":"2613_CR41","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.0000000000201485","volume":"99","author":"SL Forrest","year":"2022","unstructured":"Forrest SL, Tartaglia MC, Kim A, Alcaide-Leon P, Rogaeva E, Lang A, Kovacs GG (2022) Progressive supranuclear palsy syndrome associated with a novel tauopathy: case study. Neurology 99(24):1094\u20131098","journal-title":"Neurology"},{"key":"2613_CR42","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/s41467-022-28896-3","volume":"13","author":"N Franzmeier","year":"2022","unstructured":"Franzmeier N, Brendel M, Beyer L, Slemann L, Kovacs GG, Arzberger T, Kurz C, Respondek G, Lukic MJ, Biel D, Rubinski A, Frontzkowski L, Hummel S, M\u00c3\u00bcller A, Finze A, Palleis C, Joseph E, Weidinger E, Katzdobler S, Song M, Biechele G, Kern M, Scheifele M, Rauchmann BS, Perneczky R, Rullman M, Patt M, Schildan A, Barthel H, Sabri O, Rumpf JJ, Schroeter ML, Classen J, Villemagne V, Seibyl J, Stephens AW, Lee EB, Coughlin DG, Giese A, Grossman M, McMillan CT, Gelpi E, Molina-Porcel L, Compta Y, van Swieten JC, Laat LD, Troakes C, Al-Sarraj S, Robinson JL, Xie SX, Irwin DJ, Roeber S, Herms J, Simons M, Bartenstein P, Lee VM, Trojanowski JQ, Levin J, H\u00c3\u00b6glinger G, Ewers M, (2022) Tau deposition patterns are associated with functional connectivity in primary tauopathies. Nat Commun 13:1362","journal-title":"Nat Commun"},{"key":"2613_CR43","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/ana.23844","volume":"73","author":"RC Gardner","year":"2013","unstructured":"Gardner RC, Boxer AL, Trujillo A, Mirsky JB, Guo CC, Gennatas ED, Heuer HW, Fine E, Zhou J, Kramer JH, Miller BL, Seeley WW (2013) Intrinsic connectivity network disruption in progressive supranuclear palsy. Ann Neurol 73:603\u2013616","journal-title":"Ann Neurol"},{"key":"2613_CR44","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/arclin\/acs098","volume":"28","author":"A Gerstenecker","year":"2013","unstructured":"Gerstenecker A, Mast B, Duff K, Ferman TJ, Litvan I (2013) Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. Arch Clin Neuropsychol 28:104\u2013113","journal-title":"Arch Clin Neuropsychol"},{"key":"2613_CR45","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/mds.27196","volume":"32","author":"A Gerstenecker","year":"2017","unstructured":"Gerstenecker A, Roberson ED, Schellenberg GD, Standaert DG, Shprecher DR, Kluger BM, Litvan I (2017) Genetic influences on cognition in progressive supranuclear palsy. Mov Disord 32:1764\u20131771","journal-title":"Mov Disord"},{"key":"2613_CR46","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/jnnp.2008.155846","volume":"80","author":"BC Ghosh","year":"2009","unstructured":"Ghosh BC, Rowe JB, Calder AJ, Hodges JR, Bak TH (2009) Emotion recognition in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 80:1143\u20131145","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2613_CR47","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/brain\/aws128","volume":"135","author":"BC Ghosh","year":"2012","unstructured":"Ghosh BC, Calder AJ, Peers PV, Lawrence AD, Acosta-Cabronero J, Pereira JM, Hodges JR, Rowe JB (2012) Social cognitive deficits and their neural correlates in progressive supranuclear palsy. Brain 135:2089\u20132102","journal-title":"Brain"},{"key":"2613_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/bs.irn.2019.10.013","volume":"149","author":"N Giagkou","year":"2019","unstructured":"Giagkou N, H\u00f6glinger GU, Stamelou M (2019) Progressive supranuclear palsy. Int Rev Neurobiol 149:49\u201386","journal-title":"Int Rev Neurobiol"},{"key":"2613_CR49","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.parkreldis.2013.02.005","volume":"19","author":"A Giordano","year":"2013","unstructured":"Giordano A, Tessitore A, Corbo D, Cirillo G, de Micco R, Russo A, Liguori S, Cirillo M, Esposito F, Tedeschi G (2013) Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy. Parkinsonism Relat Disord 19:590\u2013594","journal-title":"Parkinsonism Relat Disord"},{"key":"2613_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.parkreldis.2021.01.015","volume":"84","author":"M Guasp","year":"2021","unstructured":"Guasp M, Molina-Porcel L, Painous C, Caballol N, Camara A, Perez-Soriano A, S\u00e1nchez-G\u00f3mez A, Garrido A, Mu\u00f1oz E, Marti MJ, Valldeoriola F, Grau O, Gelp\u00ed E, Respondek G, H\u00f6glinger GH, Compta Y (2021) Association of PSP phenotypes with survival: A brain-bank study. Parkinsonism Relat Disord 84:77\u201381","journal-title":"Parkinsonism Relat Disord"},{"key":"2613_CR51","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3988\/jcn.2010.6.3.148","volume":"6","author":"HJ Han","year":"2010","unstructured":"Han HJ, Kim H, Park JH, Shin HW, Kim GU, Kim DS, Lee EJ, Oh HE, Park SH, Kim YJ (2010) Behavioral changes as the earliest clinical manifestation of progressive supranuclear palsy. J Clin Neurol 6:148\u2013151","journal-title":"J Clin Neurol"},{"key":"2613_CR52","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1080\/13554794.2011.627345","volume":"18","author":"A Hassan","year":"2012","unstructured":"Hassan A, Parisi JE, Josephs KA (2012) Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia. Neurocase 18:478\u2013488","journal-title":"Neurocase"},{"key":"2613_CR53","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1212\/WNL.44.11.2015","volume":"44","author":"JJ Hauw","year":"1994","unstructured":"Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015\u20132019","journal-title":"Neurology"},{"key":"2613_CR54","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1001\/jamaneurol.2019.0250","volume":"76","author":"MG Heckman","year":"2019","unstructured":"Heckman MG, Brennan RR, Labb\u00e9 C, Soto AI, Koga S, DeTure MA, Murray ME, Petersen RC, Boeve BF, van Gerpen JA, Uitti RJ, Wszolek ZK, Rademakers R, Dickson DW, Ross OA (2019) Association of MAPT subhaplotypes with risk of progressive supranuclear palsy and severity of tau pathology. JAMA Neurol 76:710\u2013717","journal-title":"JAMA Neurol"},{"key":"2613_CR55","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1365-2990.1995.tb01056.x","volume":"21","author":"Y Higuchi","year":"1995","unstructured":"Higuchi Y, Iwaki T, Tateishi J (1995) Neurodegeneration in the limbic and paralimbic system in progressive supranuclear palsy. Neuropathol Appl Neurobiol 21:246\u2013254","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2613_CR56","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1093\/brain\/awq120","volume":"133","author":"S Hirano","year":"2010","unstructured":"Hirano S, Shinotoh H, Shimada H, Aotsuka A, Tanaka N, Ota T, Sato K, Ito H, Kuwabara S, Fukushi K, Irie T, Suhara T (2010) Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia. Brain 133:2058\u20132068","journal-title":"Brain"},{"key":"2613_CR57","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, M\u00fcller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864","journal-title":"Mov Disord"},{"key":"2613_CR58","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2018","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Muller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I (2018) Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord 32:853\u2013864","journal-title":"Mov Disord"},{"key":"2613_CR59","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/brain\/awab282","volume":"145","author":"N Holland","year":"2022","unstructured":"Holland N, Malpetti M, Rittman T, Mak EE, Passamonti L, Kaalund SS, Hezemans FH, Jones PS, Savulich G, Hong YT, Fryer TD, Aigbirhio FI, O\u2019Brien JT, Rowe JB (2022) Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study. Brain 145:340\u2013348","journal-title":"Brain"},{"key":"2613_CR60","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1007\/s00415-021-10511-y","volume":"268","author":"A Horta-Barba","year":"2021","unstructured":"Horta-Barba A, Pagonabarraga J, Mart\u00c3\u00adnez-Horta S, Busteed L, Pascual-Sedano B, Ill\u00c3\u00a1n-Gala I, Marin-Lahoz J, Aracil-Bola\u00c3\u00b1os I, P\u00c3\u00a9rez-P\u00c3\u00a9rez J, Sampedro F, Bejr-Kasem H, Kulisevsky J, (2021) Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes. J Neurol 268:3400\u20133408","journal-title":"J Neurol"},{"key":"2613_CR61","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1212\/WNL.56.12.1702","volume":"56","author":"H Houlden","year":"2001","unstructured":"Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, St George-Hyslop P, Munoz DG, Mann D, Lang AE, Bergeron C, Bigio EH, Litvan I, Bhatia KP, Dickson D, Wood NW, Hutton M (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56:1702\u20131706","journal-title":"Neurology"},{"key":"2613_CR62","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3233\/JAD-215327","volume":"88","author":"E Howard","year":"2022","unstructured":"Howard E, Ballinger S, Kinney NG, Balgenorth Y, Ehrhardt A, Phillips JS, Irwin DJ, Grossman M, Cousins KAQ (2022) Frontal atrophy and executive dysfunction relate to complex numbers impairment in progressive supranuclear palsy. J Alzheimers Dis 88:1553\u20131566","journal-title":"J Alzheimers Dis"},{"key":"2613_CR63","doi-asserted-by":"publisher","first-page":"122","DOI":"10.14802\/jmd.15033","volume":"8","author":"SY Im","year":"2015","unstructured":"Im SY, Kim YE, Kim YJ (2015) Genetics of progressive supranuclear palsy. J Mov Disord 8:122\u2013129","journal-title":"J Mov Disord"},{"key":"2613_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266405","volume":"17","author":"L Iohan","year":"2022","unstructured":"Iohan L, Lambert JC, Costa MR (2022) Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer\u2019s disease and progressive supranuclear palsy. PLoS ONE 17:e0266405","journal-title":"PLoS ONE"},{"key":"2613_CR65","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/jamaneurol.2019.4347","volume":"77","author":"E Jabbari","year":"2020","unstructured":"Jabbari E, Holland N, Chelban V, Jones PS, Lamb R, Rawlinson C, Guo T, Costantini AA, Tan MMX, Heslegrave AJ, Roncaroli F, Klein JC, Ansorge O, Allinson KSJ, Jaunmuktane Z, Holton JL, Revesz T, Warner TT, Lees AJ, Zetterberg H, Russell LL, Bocchetta M, Rohrer JD, Williams NM, Grosset DG, Burn DJ, Pavese N, Gerhard A, Kobylecki C, Leigh PN, Church A, Hu MTM, Woodside J, Houlden H, Rowe JB, Morris HR (2020) Diagnosis across the spectrum of progressive supranuclear palsy and corticobasal syndrome. JAMA Neurol 77:377\u2013387","journal-title":"JAMA Neurol"},{"key":"2613_CR66","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1474-4422(20)30394-X","volume":"20","author":"E Jabbari","year":"2021","unstructured":"Jabbari E, Koga S, Valentino RR, Reynolds RH, Ferrari R, Tan MMX, Rowe JB, Dalgard CL, Scholz SW, Dickson DW, Warner TT, Revesz T, H\u00c3\u00b6glinger GU, Ross OA, Ryten M, Hardy J, Shoai M, Morris HR, (2021) Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study. Lancet Neurol 20:107\u2013116","journal-title":"Lancet Neurol"},{"key":"2613_CR67","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000121388","volume":"5","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008) Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener Dis 5:339\u2013346","journal-title":"Neurodegener Dis"},{"key":"2613_CR68","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00702-019-02028-6","volume":"126","author":"KA Jellinger","year":"2019","unstructured":"Jellinger KA (2019) Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I Hypokinetic-Rigid Movement Disorders. J Neural Transm (vienna) 126:933\u2013995","journal-title":"J Neural Transm (Vienna)"},{"key":"2613_CR69","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00702-022-02522-4","volume":"129","author":"KA Jellinger","year":"2022","unstructured":"Jellinger KA (2022) Morphological basis of Parkinson disease-associated cognitive impairment: an update. J Neural Transm (vienna) 129:977\u2013999","journal-title":"J Neural Transm (Vienna)"},{"key":"2613_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2827","volume":"12","author":"P Jia","year":"2022","unstructured":"Jia P, Zhang J, Han J, Ji Y (2022) Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy. Brain Behav 12:e2827","journal-title":"Brain Behav"},{"key":"2613_CR71","doi-asserted-by":"publisher","unstructured":"Jin J, Su D, Zhang J, Li X, Feng T (2023) Tau PET imaging in progressive supranuclear palsy: a systematic review and meta-analysis. J Neurol. https:\/\/doi.org\/10.1007\/s00415-022-11556-3","DOI":"10.1007\/s00415-022-11556-3"},{"key":"2613_CR72","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/WCO.0b013e3283168ddd","volume":"21","author":"KA Josephs","year":"2008","unstructured":"Josephs KA, Duffy JR (2008) Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Curr Opin Neurol 21:688\u2013692","journal-title":"Curr Opin Neurol"},{"key":"2613_CR73","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1212\/WNL.41.1.25","volume":"41","author":"JL Juncos","year":"1991","unstructured":"Juncos JL, Hirsch EC, Malessa S, Duyckaerts C, Hersh LB, Agid Y (1991) Mesencephalic cholinergic nuclei in progressive supranuclear palsy. Neurology 41:25\u201330","journal-title":"Neurology"},{"key":"2613_CR74","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00401-002-0621-x","volume":"105","author":"S Kasashima","year":"2003","unstructured":"Kasashima S, Oda Y (2003) Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol 105:117\u2013124","journal-title":"Acta Neuropathol"},{"key":"2613_CR75","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00259-022-05964-w","volume":"50","author":"S Katzdobler","year":"2023","unstructured":"Katzdobler S, Nitschmann A, Barthel H, Bischof G, Beyer L, Marek K, Song M, Wagemann O, Palleis C, Weidinger E, Nack A, Fietzek U, Kurz C, H\u00e4ckert J, Stapf T, Ferschmann C, Scheifele M, Eckenweber F, Biechele G, Franzmeier N, Dewenter A, Sch\u00f6necker S, Saur D, Schroeter ML, Rumpf JJ, Rullmann M, Schildan A, Patt M, Stephens AW, van Eimeren T, Neumaier B, Drzezga A, Danek A, Classen J, B\u00fcrger K, Janowitz D, Rauchmann BS, St\u00f6cklein S, Perneczky R, Sch\u00f6berl F, Zwergal A, H\u00f6glinger GU, Bartenstein P, Villemagne V, Seibyl J, Sabri O, Levin J, Brendel M (2023) Additive value of [(18)F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome. Eur J Nucl Med Mol Imaging 50:423\u2013434","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2613_CR76","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.gaitpost.2014.07.005","volume":"40","author":"SL Kim","year":"2014","unstructured":"Kim SL, Lee MJ, Lee MS (2014) Cognitive dysfunction associated with falls in progressive supranuclear palsy. Gait Posture 40:605\u2013609","journal-title":"Gait Posture"},{"key":"2613_CR77","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s00415-015-7657-z","volume":"262","author":"C Kobylecki","year":"2015","unstructured":"Kobylecki C, Jones M, Thompson JC, Richardson AM, Neary D, Mann DM, Snowden JS, Gerhard A (2015) Cognitive-behavioural features of progressive supranuclear palsy syndrome overlap with frontotemporal dementia. J Neurol 262:916\u2013922","journal-title":"J Neurol"},{"key":"2613_CR78","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/mds.27198","volume":"32","author":"S Koga","year":"2017","unstructured":"Koga S, Parks A, Kasanuki K, Sanchez-Contreras M, Baker MC, Josephs KA, Ahlskog JE, Uitti RJ, Graff-Radford N, van Gerpen JA, Wszolek ZK, Rademakers R, Dickson DW (2017) Cognitive impairment in progressive supranuclear palsy is associated with tau burden. Mov Disord 32:1772\u20131779","journal-title":"Mov Disord"},{"key":"2613_CR79","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","volume":"140","author":"GG Kovacs","year":"2020","unstructured":"Kovacs GG, Lukic MJ, Irwin DJ, Arzberger T, Respondek G, Lee EB, Coughlin D, Giese A, Grossman M, Kurz C, McMillan CT, Gelpi E, Compta Y, van Swieten JC, Laat LD, Troakes C, Al-Sarraj S, Robinson JL, Roeber S, Xie SX, Lee VM, Trojanowski JQ, H\u00f6glinger GU (2020) Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol 140:99\u2013119","journal-title":"Acta Neuropathol"},{"key":"2613_CR80","doi-asserted-by":"publisher","first-page":"72","DOI":"10.14802\/jmd.17067","volume":"11","author":"YC Lee","year":"2018","unstructured":"Lee YC, Williams DR, Anderson JFI (2018) Prospective characterization of cognitive function in typical and \u201cbrainstem predominant\u201d progressive supranuclear palsy phenotypes. J Mov Disord 11:72\u201377","journal-title":"J Mov Disord"},{"key":"2613_CR81","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00005072-199601000-00010","volume":"55","author":"I Litvan","year":"1996","unstructured":"Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, Anderson DW (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55:97\u2013105","journal-title":"J Neuropathol Exp Neurol"},{"key":"2613_CR82","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-06104-0","author":"FT Liu","year":"2023","unstructured":"Liu FT, Lu JY, Li XY, Liang XN, Jiao FY, Ge JJ, Wu P, Li G, Shen B, Wu B, Sun YM, Zhu YH, Luo JF, Yen TC, Wu JJ, Zuo CT, Wang J (2023a) (18)F-Florzolotau PET imaging captures the distribution patterns and regional vulnerability of tau pathology in progressive supranuclear palsy. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-00022-06104-00250","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2613_CR83","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/brain\/awac327","volume":"146","author":"G Liu","year":"2023","unstructured":"Liu G, Ni C, Zhan J, Li W, Luo J, Liao Z, Locascio JJ, Xian W, Chen L, Pei Z, Corvol JC, Maple-Gr\u00f8dem J, Campbell MC, Elbaz A, Lesage S, Brice A, Hung AY, Schwarzschild MA, Hayes MT, Wills AM, Ravina B, Shoulson I, Taba P, K\u00f5ks S, Beach TG, Cormier-Dequaire F, Alves G, Tysnes OB, Perlmutter JS, Heutink P, van Hilten JJ, Barker RA, Williams-Gray CH, Scherzer CR (2023b) Mitochondrial haplogroups and cognitive progression in Parkinson\u2019s disease. Brain 146:42\u201349","journal-title":"Brain"},{"key":"2613_CR84","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3233\/JAD-210023","volume":"80","author":"A Luca","year":"2021","unstructured":"Luca A, Nicoletti A, Donzuso G, Terravecchia C, Cicero CE, D\u2019Agate C, Rascun\u00e1 C, Manna R, Mostile G, Zappia M (2021) Phonemic verbal fluency and midbrain atrophy in progressive supranuclear palsy. J Alzheimers Dis 80:1669\u20131674","journal-title":"J Alzheimers Dis"},{"key":"2613_CR85","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1007\/s10072-022-06160-2","volume":"43","author":"AC Macedo","year":"2022","unstructured":"Macedo AC, Caramelli P, de Paula Fran\u00e7a Resende E, Mariano LI, Tumas V, Teixeira AL, Camargos ST, Cardoso FEC, de Souza LC, (2022a) Episodic memory in progressive supranuclear palsy: a neuropsychological and neuroimaging study. Neurol Sci 43:5363\u20135368","journal-title":"Neurol Sci"},{"key":"2613_CR86","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/mdc3.13435","volume":"9","author":"AC Macedo","year":"2022","unstructured":"Macedo AC, Mariano LI, Martins MI, Friedlaender CV, Ventura JM, de Faria Rocha JV, Camargos ST, Cardoso FEC, Caramelli P, de Souza LC (2022b) Do patients with progressive supranuclear palsy have episodic memory impairment? A systematic review. Mov Disord Clin Pract 9:436\u2013445","journal-title":"Mov Disord Clin Pract"},{"key":"2613_CR87","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/ana.25911","volume":"88","author":"M Malpetti","year":"2020","unstructured":"Malpetti M, Passamonti L, Rittman T, Jones PS, V\u00e1zquez Rodr\u00edguez P, Bevan-Jones WR, Hong YT, Fryer TD, Aigbirhio FI, O\u2019Brien JT, Rowe JB (2020) Neuroinflammation and tau colocalize in vivo in progressive supranuclear palsy. Ann Neurol 88:1194\u20131204","journal-title":"Ann Neurol"},{"key":"2613_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120514","volume":"444","author":"K Matsuoka","year":"2023","unstructured":"Matsuoka K, Takado Y, Tagai K, Kubota M, Sano Y, Takahata K, Ono M, Seki C, Matsumoto H, Endo H, Shinotoh H, Sahara Y, Obata T, Near J, Kawamura K, Zhang MR, Suhara T, Shimada H, Higuchi M (2023) Two pathways differentially linking tau depositions, oxidative stress, and neuronal loss to apathetic phenotypes in progressive supranuclear palsy. J Neurol Sci 444:120514","journal-title":"J Neurol Sci"},{"key":"2613_CR89","first-page":"1754","volume":"63","author":"K Messerschmidt","year":"2022","unstructured":"Messerschmidt K, Barthel H, Brendel M, Scherlach C, Hoffmann KT, Rauchmann BS, Rullmann M, Marek K, Villemagne VL, Rumpf JJ, Saur D, Schroeter ML, Schildan A, Patt M, Beyer L, Song M, Palleis C, Katzdobler S, Fietzek UM, Respondek G, Scheifele M, Nitschmann A, Zach C, Barret O, Madonia J, Russell D, Stephens AW, Koglin N, Roeber S, Herms J, B\u00f6tzel K, Bartenstein P, Levin J, Seibyl JP, H\u00f6glinger G, Classen J, Sabri O (2022) (18)F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy. J Nucl Med 63:1754\u20131760","journal-title":"J Nucl Med"},{"key":"2613_CR90","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13112","volume":"33","author":"M Montalbano","year":"2023","unstructured":"Montalbano M, Majmundar L, Sengupta U, Fung L, Kayed R (2023) Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer\u2019s disease, progressive supranuclear palsy, and dementia with Lewy bodies. Brain Pathol 33:e13112","journal-title":"Brain Pathol"},{"key":"2613_CR91","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Chui HC, Fardo DW, Flanagan ME, Halliday G, Hokkanen SRK, Hunter S, Jicha GA, Katsumata Y, Kawas CH, Keene CD, Kovacs GG, Kukull WA, Levey AI, Makkinejad N, Montine TJ, Murayama S, Murray ME, Nag S, Rissman RA, Seeley WW, Sperling RA, White CL 3rd, Yu L, Schneider JA (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142:1503\u20131527","journal-title":"Brain"},{"key":"2613_CR92","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00415-019-09566-9","volume":"267","author":"N Nicastro","year":"2020","unstructured":"Nicastro N, Rodriguez PV, Malpetti M, Bevan-Jones WR, Simon Jones P, Passamonti L, Aigbirhio FI, O\u2019Brien JT, Rowe JB (2020) (18)F-AV1451 PET imaging and multimodal MRI changes in progressive supranuclear palsy. J Neurol 267:341\u2013349","journal-title":"J Neurol"},{"key":"2613_CR93","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/neup.12805","volume":"42","author":"Y Ono","year":"2022","unstructured":"Ono Y, Higashida K, Yoshikura N, Hayashi Y, Kimura A, Iwasaki Y, Yoshida M, Shimohata T (2022) Progressive supranuclear palsy with predominant frontal presentation exhibiting progressive nonfluent aphasia due to crossed aphasia. Neuropathology 42:232\u2013238","journal-title":"Neuropathology"},{"key":"2613_CR94","doi-asserted-by":"publisher","first-page":"80941","DOI":"10.18632\/oncotarget.20895","volume":"8","author":"P Pan","year":"2017","unstructured":"Pan P, Liu Y, Zhang Y, Zhao H, Ye X, Xu Y (2017) Brain gray matter abnormalities in progressive supranuclear palsy revisited. Oncotarget 8:80941\u201380955","journal-title":"Oncotarget"},{"key":"2613_CR95","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/07317115.2019.1694115","volume":"43","author":"TP Parthimos","year":"2020","unstructured":"Parthimos TP, Schulpis KH (2020) The progressive supranuclear palsy: past and present aspects. Clin Gerontol 43:155\u2013180","journal-title":"Clin Gerontol"},{"key":"2613_CR96","first-page":"781","volume":"140","author":"L Passamonti","year":"2017","unstructured":"Passamonti L, V\u00e1zquez Rodr\u00edguez P, Hong YT, Allinson KS, Williamson D, Borchert RJ, Sami S, Cope TE, Bevan-Jones WR, Jones PS, Arnold R, Surendranathan A, Mak E, Su L, Fryer TD, Aigbirhio FI, O\u2019Brien JT, Rowe JB (2017) 18F-AV-1451 positron emission tomography in Alzheimer\u2019s disease and progressive supranuclear palsy. Brain 140:781\u2013791","journal-title":"Brain"},{"key":"2613_CR97","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2017.10.002","volume":"45","author":"C Pellicano","year":"2017","unstructured":"Pellicano C, Assogna F, Cellupica N, Piras F, Pierantozzi M, Stefani A, Cerroni R, Mercuri B, Caltagirone C, Pontieri FE, Spalletta G (2017) Neuropsychiatric and cognitive profile of early Richardson\u2019s syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson\u2019s disease. Parkinsonism Relat Disord 45:50\u201356","journal-title":"Parkinsonism Relat Disord"},{"key":"2613_CR98","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3174\/ajnr.A4229","volume":"36","author":"MC Piattella","year":"2015","unstructured":"Piattella MC, Tona F, Bologna M, Sbardella E, Formica A, Petsas N, Filippini N, Berardelli A, Pantano P (2015a) Disrupted resting-state functional connectivity in progressive supranuclear palsy. AJNR Am J Neuroradiol 36:915\u2013921","journal-title":"AJNR Am J Neuroradiol"},{"key":"2613_CR99","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1007\/s00415-015-7779-3","volume":"262","author":"MC Piattella","year":"2015","unstructured":"Piattella MC, Upadhyay N, Bologna M, Sbardella E, Tona F, Formica A, Petsas N, Berardelli A, Pantano P (2015b) Neuroimaging evidence of gray and white matter damage and clinical correlates in progressive supranuclear palsy. J Neurol 262:1850\u20131858","journal-title":"J Neurol"},{"key":"2613_CR100","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00415-019-09324-x","volume":"266","author":"M Picillo","year":"2019","unstructured":"Picillo M, Cuoco S, Tepedino MF, Cappiello A, Volpe G, Erro R, Santangelo G, Pellecchia MT, Barone P (2019) Motor, cognitive and behavioral differences in MDS PSP phenotypes. J Neurol 266:1727\u20131735","journal-title":"J Neurol"},{"key":"2613_CR101","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1212\/WNL.41.5.634","volume":"41","author":"B Pillon","year":"1991","unstructured":"Pillon B, Dubois B, Ploska A, Agid Y (1991) Severity and specificity of cognitive impairment in Alzheimer\u2019s, Huntington\u2019s, and Parkinson\u2019s diseases and progressive supranuclear palsy. Neurology 41:634\u2013643","journal-title":"Neurology"},{"key":"2613_CR102","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000479110","volume":"17","author":"A Pilotto","year":"2017","unstructured":"Pilotto A, Gazzina S, Benussi A, Manes M, Dell\u2019Era V, Cristillo V, Cosseddu M, Turrone R, Alberici A, Padovani A, Borroni B (2017) Mild cognitive impairment and progression to dementia in progressive supranuclear palsy. Neurodegener Dis 17:286\u2013291","journal-title":"Neurodegener Dis"},{"key":"2613_CR103","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1148\/radiol.2453061703","volume":"246","author":"A Quattrone","year":"2008","unstructured":"Quattrone A, Nicoletti G, Messina D, Fera F, Condino F, Pugliese P, Lanza P, Barone P, Morgante L, Zappia M, Aguglia U, Gallo O (2008) MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 246:214\u2013221","journal-title":"Radiology"},{"key":"2613_CR104","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00702-022-02524-2","volume":"129","author":"L Ransmayr","year":"2022","unstructured":"Ransmayr L, Fuchs A, Ransmayr-Tepser S, Kommenda R, K\u00f6gl M, Schwingenschuh P, Fellner F, Guger M, Eggers C, Darkow R, Mangesius S, Ransmayr G (2022) Differences in aphasia syndromes between progressive supranuclear palsy-Richardson\u2019s syndrome, behavioral variant frontotemporal dementia and Alzheimer\u2019s dementia. J Neural Transm (vienna) 129:1039\u20131048","journal-title":"J Neural Transm (vienna)"},{"key":"2613_CR105","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/mds.26054","volume":"29","author":"G Respondek","year":"2014","unstructured":"Respondek G, Stamelou M, Kurz C, Ferguson LW, Rajput A, Chiu WZ, van Swieten JC, Troakes C, Al Sarraj S, Gelpi E, Gaig C, Tolosa E, Oertel WH, Giese A, Roeber S, Arzberger T, Wagenpfeil S, H\u00f6glinger GU (2014) The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord 29:1758\u20131766","journal-title":"Mov Disord"},{"key":"2613_CR106","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.27034","volume":"32","author":"G Respondek","year":"2017","unstructured":"Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, M\u00c3\u00bcller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, H\u00c3\u00f6glinger GU, (2017) Which ante mortem clinical features predict progressive supranuclear palsy pathology? Mov Disord 32:995\u20131005","journal-title":"Mov Disord"},{"key":"2613_CR107","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s12031-011-9606-3","volume":"45","author":"V Ries","year":"2011","unstructured":"Ries V, Oertel WH, H\u00f6glinger GU (2011) Mitochondrial dysfunction as a therapeutic target in progressive supranuclear palsy. J Mol Neurosci 45:684\u2013689","journal-title":"J Mol Neurosci"},{"key":"2613_CR108","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/jnen\/nlz141","volume":"79","author":"JL Robinson","year":"2020","unstructured":"Robinson JL, Yan N, Caswell C, Xie SX, Suh E, Van Deerlin VM, Gibbons G, Irwin DJ, Grossman M, Lee EB, Lee VM, Miller B, Trojanowski JQ (2020) Primary tau pathology, not copathology, correlates with clinical symptoms in PSP and CBD. J Neuropathol Exp Neurol 79:296\u2013304","journal-title":"J Neuropathol Exp Neurol"},{"key":"2613_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.851788","volume":"14","author":"S Rogozinski","year":"2022","unstructured":"Rogozinski S, Klietz M, Respondek G, Oertel WH, Grothe MJ, Pereira JB, H\u00f6glinger GU (2022) Reduction in volume of nucleus basalis of Meynert is specific to Parkinson\u2019s disease and progressive supranuclear palsy but not to multiple system atrophy. Front Aging Neurosci 14:851788","journal-title":"Front Aging Neurosci"},{"key":"2613_CR110","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/mds.27039","volume":"32","author":"J Rosskopf","year":"2017","unstructured":"Rosskopf J, Gorges M, M\u00c3\u00bcller HP, Lul\u00c3\u00a9 D, Uttner I, Ludolph AC, Pinkhardt E, Juengling FD, Kassubek J, (2017) Intrinsic functional connectivity alterations in progressive supranuclear palsy: Differential effects in frontal cortex, motor, and midbrain networks. Mov Disord 32:1006\u20131015","journal-title":"Mov Disord"},{"key":"2613_CR111","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-017-0162-3","volume":"12","author":"L Saint-Aubert","year":"2017","unstructured":"Saint-Aubert L, Lemoine L, Chiotis K, Leuzy A, Rodriguez-Vieitez E, Nordberg A (2017) Tau PET imaging: present and future directions. Mol Neurodegener 12:19","journal-title":"Mol Neurodegener"},{"key":"2613_CR112","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/mds.27816","volume":"34","author":"N Sakae","year":"2019","unstructured":"Sakae N, Josephs KA, Litvan I, Murray ME, Duara R, Uitti RJ, Wszolek ZK, Graff-Radford NR, Dickson DW (2019) Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy. Mov Disord 34:1655\u20131662","journal-title":"Mov Disord"},{"key":"2613_CR113","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1440-1789.2008.00968.x","volume":"29","author":"R Sakamoto","year":"2009","unstructured":"Sakamoto R, Tsuchiya K, Yoshida R, Itoh Y, Furuta N, Kosuga A, Sugai Y, Mimura M (2009) Progressive supranuclear palsy combined with Alzheimer\u2019s disease: a clinicopathological study of two autopsy cases. Neuropathology 29:219\u2013229","journal-title":"Neuropathology"},{"key":"2613_CR114","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3233\/JAD-2010-101011","volume":"22","author":"L Samaranch","year":"2010","unstructured":"Samaranch L, Cervantes S, Barabash A, Alonso A, Cabranes JA, Lamet I, Anc\u00edn I, Lorenzo E, Mart\u00ednez-Lage P, Marcos A, Clarim\u00f3n J, Alcolea D, Lle\u00f3 A, Blesa R, G\u00f3mez-Isla T, Pastor P (2010) The effect of MAPT H1 and APOE epsilon 4 on transition from mild cognitive impairment to dementia. J Alzheimers Dis 22:1065\u20131071","journal-title":"J Alzheimers Dis"},{"key":"2613_CR115","doi-asserted-by":"publisher","first-page":"S307","DOI":"10.1007\/s00415-011-6016-y","volume":"258","author":"AH Schapira","year":"2011","unstructured":"Schapira AH (2011) Aetiopathogenesis of Parkinson\u2019s disease. J Neurol 258:S307-310","journal-title":"J Neurol"},{"key":"2613_CR116","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s00415-011-6205-8","volume":"259","author":"EC Schofield","year":"2012","unstructured":"Schofield EC, Hodges JR, Bak TH, Xuereb JH, Halliday GM (2012) The relationship between clinical and pathological variables in Richardson\u2019s syndrome. J Neurol 259:482\u2013490","journal-title":"J Neurol"},{"key":"2613_CR117","doi-asserted-by":"publisher","first-page":"fcac098","DOI":"10.1093\/braincomms\/fcac098","volume":"4","author":"WJ Scotton","year":"2022","unstructured":"Scotton WJ, Bocchetta M, Todd E, Cash DM, Oxtoby N, VandeVrede L, Heuer H, Alexander DC, Rowe JB, Morris HR, Boxer A, Rohrer JD, Wijeratne PA (2022) A data-driven model of brain volume changes in progressive supranuclear palsy. Brain Commun 4:fcac098","journal-title":"Brain Commun"},{"key":"2613_CR118","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3389\/fneur.2019.01125","volume":"10","author":"A Shoeibi","year":"2019","unstructured":"Shoeibi A, Olfati N, Litvan I (2019) Frontrunner in translation: progressive supranuclear palsy. Front Neurol 10:1125","journal-title":"Front Neurol"},{"key":"2613_CR119","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.parkreldis.2019.07.001","volume":"66","author":"I Sintini","year":"2019","unstructured":"Sintini I, Schwarz CG, Senjem ML, Reid RI, Botha H, Ali F, Ahlskog JE, Jack CR Jr, Lowe VJ, Josephs KA, Whitwell JL (2019) Multimodal neuroimaging relationships in progressive supranuclear palsy. Parkinsonism Relat Disord 66:56\u201361","journal-title":"Parkinsonism Relat Disord"},{"key":"2613_CR120","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cortex.2018.07.004","volume":"122","author":"DT Smith","year":"2020","unstructured":"Smith DT, Archibald N (2020) Spatial working memory in Progressive Supranuclear Palsy. Cortex 122:115\u2013122","journal-title":"Cortex"},{"key":"2613_CR121","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cortex.2020.12.019","volume":"137","author":"DT Smith","year":"2021","unstructured":"Smith DT, Casteau S, Archibald N (2021) Spatial attention and spatial short term memory in PSP and Parkinson\u2019s disease. Cortex 137:49\u201360","journal-title":"Cortex"},{"key":"2613_CR122","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3233\/JPD-191744","volume":"10","author":"CD Stang","year":"2020","unstructured":"Stang CD, Turcano P, Mielke MM, Josephs KA, Bower JH, Ahlskog JE, Boeve BF, Martin PR, Upadhyaya SG, Savica R (2020) Incidence and trends of progressive supranuclear palsy and corticobasal syndrome: a population-based study. J Parkinsons Dis 10:179\u2013184","journal-title":"J Parkinsons Dis"},{"key":"2613_CR123","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ng1508","volume":"37","author":"H Stefansson","year":"2005","unstructured":"Stefansson H, Helgason A, Thorleifsson G, Steinthorsdottir V, Masson G, Barnard J, Baker A, Jonasdottir A, Ingason A, Gudnadottir VG, Desnica N, Hicks A, Gylfason A, Gudbjartsson DF, Jonsdottir GM, Sainz J, Agnarsson K, Birgisdottir B, Ghosh S, Olafsdottir A, Cazier JB, Kristjansson K, Frigge ML, Thorgeirsson TE, Gulcher JR, Kong A, Stefansson K (2005) A common inversion under selection in Europeans. Nat Genet 37:129\u2013137","journal-title":"Nat Genet"},{"key":"2613_CR124","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.parkreldis.2016.12.023","volume":"36","author":"A Stezin","year":"2017","unstructured":"Stezin A, Lenka A, Jhunjhunwala K, Saini J, Pal PK (2017) Advanced structural neuroimaging in progressive supranuclear palsy: Where do we stand? Parkinsonism Relat Disord 36:19\u201332","journal-title":"Parkinsonism Relat Disord"},{"key":"2613_CR125","doi-asserted-by":"publisher","first-page":"fcab206","DOI":"10.1093\/braincomms\/fcab206","volume":"3","author":"D Street","year":"2021","unstructured":"Street D, Malpetti M, Rittman T, Ghosh BCP, Murley AG, Coyle-Gilchrist I, Passamonti L, Rowe JB (2021) Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants. Brain Commun 3:fcab206","journal-title":"Brain Commun"},{"key":"2613_CR126","doi-asserted-by":"publisher","first-page":"562","DOI":"10.4103\/jnrp.jnrp_154_17","volume":"8","author":"GD Sulena","year":"2017","unstructured":"Sulena GD, Sharma AK, Kumar N (2017) Clinical profile of cognitive decline in patients with Parkinson\u2019s disease, progressive supranuclear palsy, and multiple system atrophy. J Neurosci Rural Pract 8:562\u2013568","journal-title":"J Neurosci Rural Pract"},{"key":"2613_CR127","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1212\/WNL.58.7.1013","volume":"58","author":"M Suzuki","year":"2002","unstructured":"Suzuki M, Desmond TJ, Albin RL, Frey KA (2002) Cholinergic vesicular transporters in progressive supranuclear palsy. Neurology 58:1013\u20131018","journal-title":"Neurology"},{"key":"2613_CR128","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejmp.2022.04.016","volume":"98","author":"P Tom\u0161e","year":"2022","unstructured":"Tom\u0161e P, Rebec E, Studen A, Perovnik M, Rus T, Le\u017eaic L, Tang CC, Eidelberg D, Tro\u0161t M (2022) Abnormal metabolic covariance patterns associated with multiple system atrophy and progressive supranuclear palsy. Phys Med 98:131\u2013138","journal-title":"Phys Med"},{"key":"2613_CR129","doi-asserted-by":"publisher","DOI":"10.1172\/JCI149904","volume":"132","author":"X Wang","year":"2022","unstructured":"Wang X, Allen M, Is \u00d6, Reddy JS, Tutor-New FQ, Castanedes Casey M, Carrasquillo MM, Oatman SR, Min Y, Asmann YW, Funk C, Nguyen T, Ho CC, Malphrus KG, Seyfried NT, Levey AI, Younkin SG, Murray ME, Dickson DW, Price ND, Golde TE, Ertekin-Taner N (2022) Alzheimer\u2019s disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions. J Clin Invest 132:e149904","journal-title":"J Clin Invest"},{"key":"2613_CR130","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/jnnp.2006.099937","volume":"78","author":"NM Warren","year":"2007","unstructured":"Warren NM, Piggott MA, Lees AJ, Burn DJ (2007a) The basal ganglia cholinergic neurochemistry of progressive supranuclear palsy and other neurodegenerative diseases. J Neurol Neurosurg Psychiatry 78:571\u2013575","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2613_CR131","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/nen.0b013e318053db64","volume":"66","author":"NM Warren","year":"2007","unstructured":"Warren NM, Piggott MA, Lees AJ, Burn DJ (2007b) Muscarinic receptors in the thalamus in progressive supranuclear palsy and other neurodegenerative disorders. J Neuropathol Exp Neurol 66:399\u2013404","journal-title":"J Neuropathol Exp Neurol"},{"key":"2613_CR132","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jchemneu.2008.01.001","volume":"35","author":"NM Warren","year":"2008","unstructured":"Warren NM, Piggott MA, Lees AJ, Perry EK, Burn DJ (2008) Intact coupling of M1 receptors and preserved M2 and M4 receptors in the cortex in progressive supranuclear palsy: contrast with other dementias. J Chem Neuroanat 35:268\u2013274","journal-title":"J Chem Neuroanat"},{"key":"2613_CR133","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3233\/JPD-202302","volume":"11","author":"Y Wen","year":"2021","unstructured":"Wen Y, Zhou Y, Jiao B, Shen L (2021) Genetics of progressive supranuclear palsy: a review. J Parkinsons Dis 11:93\u2013105","journal-title":"J Parkinsons Dis"},{"key":"2613_CR134","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/ene.12212","volume":"20","author":"JL Whitwell","year":"2013","unstructured":"Whitwell JL, Jack CR Jr, Parisi JE, Gunter JL, Weigand SD, Boeve BF, Ahlskog JE, Petersen RC, Dickson DW, Josephs KA (2013) Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Eur J Neurol 20:1417\u20131422","journal-title":"Eur J Neurol"},{"key":"2613_CR135","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/mds.26834","volume":"32","author":"JL Whitwell","year":"2017","unstructured":"Whitwell JL, Lowe VJ, Tosakulwong N, Weigand SD, Senjem ML, Schwarz CG, Spychalla AJ, Petersen RC, Jack CR Jr, Josephs KA (2017) [(18) F]AV-1451 tau positron emission tomography in progressive supranuclear palsy. Mov Disord 32:124\u2013133","journal-title":"Mov Disord"},{"key":"2613_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.102152","volume":"25","author":"JL Whitwell","year":"2020","unstructured":"Whitwell JL, Tosakulwong N, Botha H, Ali F, Clark HM, Duffy JR, Utianski RL, Stevens CA, Weigand SD, Schwarz CG, Senjem ML, Jack CR, Lowe VJ, Ahlskog JE, Dickson DW, Josephs KA (2020) Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants. Neuroimage Clin 25:102152","journal-title":"Neuroimage Clin"},{"key":"2613_CR137","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","volume":"8","author":"DR Williams","year":"2009","unstructured":"Williams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 8:270\u2013279","journal-title":"Lancet Neurol"},{"key":"2613_CR138","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/brain\/awm104","volume":"130","author":"DR Williams","year":"2007","unstructured":"Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ, Revesz T (2007) Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson\u2019s syndrome. Brain 130:1566\u20131576","journal-title":"Brain"},{"key":"2613_CR139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112638","volume":"9","author":"A Worker","year":"2014","unstructured":"Worker A, Blain C, Jarosz J, Chaudhuri KR, Barker GJ, Williams SC, Brown RG, Leigh PN, Dell\u2019Acqua F, Simmons A (2014) Diffusion tensor imaging of Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study. PLoS ONE 9:e112638","journal-title":"PLoS ONE"},{"key":"2613_CR140","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/ana.410410509","volume":"41","author":"H Yamauchi","year":"1997","unstructured":"Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Konishi J, Kimura J (1997) Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy. Ann Neurol 41:606\u2013614","journal-title":"Ann Neurol"},{"key":"2613_CR141","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-010-0702-1","volume":"120","author":"O Yokota","year":"2010","unstructured":"Yokota O, Davidson Y, Bigio EH, Ishizu H, Terada S, Arai T, Hasegawa M, Akiyama H, Sikkink S, Pickering-Brown S, Mann DM (2010) Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol 120:55\u201366","journal-title":"Acta Neuropathol"},{"key":"2613_CR142","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/neup.12707","volume":"41","author":"L Zhang","year":"2021","unstructured":"Zhang L, Toyoshima Y, Takeshima A, Shimizu H, Tomita I, Onodera O, Takahashi H, Kakita A (2021) Progressive supranuclear palsy: neuropathology of patients with a short disease duration due to unexpected death. Neuropathology 41:174\u2013182","journal-title":"Neuropathology"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-023-02613-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-023-02613-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-023-02613-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T13:07:52Z","timestamp":1680008872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-023-02613-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":142,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2613"],"URL":"https:\/\/doi.org\/10.1007\/s00702-023-02613-w","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]},"assertion":[{"value":"16 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}